Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganciclovir ophthalmic gel vs saline in acute adenoviral conjunctivitis
2014-002319-41Phase 2Active
- Sponsor
- Ana Boto de los Bueis
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of GV550 in adenoviral conjunctivitis (2 arms), sponsored by Ana Boto de los Bueis. Primary endpoint: Conjunctival viral load. Started Aug 2014; status: active.
02
Drugs
GV550
03
Conditions
adenoviral conjunctivitis
Beyond the preview
Go deeper on 2014-002319-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002319-41.